A carregar...

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol

INTRODUCTION: It has been argued that tapentadol may pharmacologically have lower abuse potential than other pharmaceutical opioids currently available. However, there has been no comprehensive triangulation of data regarding use and harms associated with this formulation. A sustained-release formul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Peacock, Amy, Larance, Briony, Farrell, Michael, Cairns, Rose, Buckley, Nicholas, Degenhardt, Louisa
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875643/
https://ncbi.nlm.nih.gov/pubmed/29574444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-020006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!